RE:HEXO Projected Annual Sales (without US Legalization)Based on earning vs. sharecounts (earnings ratio using trailer 4 QTR method) and using the lower range ratios seen on Canopy in 2021 we can project out a fair market value for HEXO shares above $20 per share. This does not include the incremental sales that we will see from Zenabis, 48-North, nor does it include the incremental quarterly sales from Redecan of $58 Million. Once we start adding those numbers into the equation the fair market value of shares goes up.
We may need to wait for the next QTR report to come out for those sales figures to be reflected in the SP however I am certainly willing to wait.
JMHO / DYODD
Q
quinlash wrote: Yesterday we were discussing annual sales for HEXO based on their last QTR report plus the sales figures that can be reasonabily expected from the companies that it is acquiring. Those numbers are based on CURRENT market share within Canada, the sales it is pulling in from overseas sales and the sales from drinks in the US that it has already established through Molson-Coors.
HEXO noted expanson plans into other states as laws allow so we will have to wait and see which states these actually include.
HEXO last QTR was $33 Million CDN
Zenabis was $16 Million CDN
48 North was $5.5 Million
Redecan was $58 Million
Add it all up you get 112.5 Million CDN per QTR
x4 for annual projections just get just under 1/2 Billion in sales.
add in some incremental with the 1000 new stores opening in Ontario, some sales overseas to Isreal, some more sales out of the US... you're over 1/2 Billion annually.
Add that into your earnings ratio math, the price doesn't work out to $7 / share, nor does it work out to $14, it's higher, much higher
Q